Arvinas, Inc. (ARVN) vs NeoGenomics, Inc. (NEO)

A side-by-side comparison of Arvinas, Inc. and NeoGenomics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ARVN vs NEO

growth of $100 · dividends reinvested · last 8y
ARVN -53.5% (-9.1%/yr)NEO +25.3% (+2.9%/yr)NEO compounded faster over this window
0200400600Start $1002020202220242026$46$125
ARVN NEO

ARVN vs NEO: by the numbers

  • •ARVN is the larger company ($472M vs $424M market cap).
  • •ARVN is profitable (2.94% net margin) while NEO runs a net loss (-6.77%).
  • •ARVN grew revenue faster over the past five years (72.38% vs 9.41% CAGR).

Metrics side by side

Valuation

MetricARVNNEO
P/E ratio45.69N/A
Forward P/EN/A90.32
P/S ratio1.490.55
P/B ratio0.840.54

Profitability

MetricARVNNEO
Gross margin96.43%42.92%
Operating margin-43.75%-8.63%
Net margin2.94%-6.77%
ROE1.65%-6.60%
ROIC-2.19%-5.29%

Growth (annualized)

MetricARVNNEO
Revenue CAGR (5Y)72.38%9.41%
Total return CAGR (5Y)-38.16%-15.14%

Frequently asked

Which has grown faster, ARVN or NEO?
Over the past five years, ARVN grew revenue faster — ARVN at a 72.38% CAGR versus NEO at 9.41%.
Is ARVN or NEO more profitable?
ARVN runs the higher net margin — ARVN at 2.94% versus NEO at -6.77%.
How have ARVN and NEO total returns compared?
Over the past 5 years, ARVN delivered -38.16% and NEO delivered -15.14% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.